Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive hispanic postmenopausal women

Richard A Preston, David Afshartous, Barry J Materson, Rolando Rodco, Alberto B. Alonso

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Several consistent lines of evidence indicate an association between sodium sensitivity and impaired nitric oxide bioactivity. Nevertheless, whether restoring nitric oxide in humans by pharmacological means can ameliorate sodium sensitivity has not been investigated. Because nebivolol has been demonstrated to increase nitric oxide bioactivity in both laboratory and clinical investigations, we hypothesized that nebivolol might ameliorate sodium sensitivity and improve renal sodium handling in comparison to metoprolol. We therefore conducted a randomized, 2-treatment-period crossover trial in 19 Hispanic postmenopausal women with hypertension to determine the comparative effects of nebivolol versus metoprolol on (1) 24-hour ambulatory blood pressure response to an increase in dietary sodium from 5 days of low sodium to 5 days of high sodium, (2) renal natriuretic response to a 1-L saline challenge, and (3) asymmetrical dimethylarginine. Clinic blood pressure and heart rate were significantly reduced after 4 weeks of treatment with both nebivolol and metoprolol. Twenty-four-hour mean systolic blood pressure increased sharply from low sodium to high sodium for both nebivolol and metoprolol. Nevertheless, the increases in blood pressure did not differ between the 2 drugs: 7.7 (3.1, 12.3) mm Hg with metoprolol and 9.3 (4.6, 13.9) mm Hg with nebivolol (P=0.63). Furthermore, we observed no differences between the drugs in natriuretic response to saline challenge or asymmetrical dimethylarginine. In a sodium-sensitive population, at doses sufficient to produce reductions in blood pressure and heart rate, nebivolol did not demonstrate a significant effect on sodium sensitivity or sodium handling compared with metoprolol.

Original languageEnglish
Pages (from-to)287-295
Number of pages9
JournalHypertension
Volume64
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Nebivolol
Metoprolol
Hispanic Americans
Sodium
Kidney
Blood Pressure
Nitric Oxide
Heart Rate
Dietary Sodium

Keywords

  • hypertension
  • kidney
  • nitric oxide
  • sodium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive hispanic postmenopausal women. / Preston, Richard A; Afshartous, David; Materson, Barry J; Rodco, Rolando; Alonso, Alberto B.

In: Hypertension, Vol. 64, No. 2, 01.01.2014, p. 287-295.

Research output: Contribution to journalArticle

Preston, Richard A ; Afshartous, David ; Materson, Barry J ; Rodco, Rolando ; Alonso, Alberto B. / Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive hispanic postmenopausal women. In: Hypertension. 2014 ; Vol. 64, No. 2. pp. 287-295.
@article{83d740b3b1dc4a8c8873a01c63120a55,
title = "Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive hispanic postmenopausal women",
abstract = "Several consistent lines of evidence indicate an association between sodium sensitivity and impaired nitric oxide bioactivity. Nevertheless, whether restoring nitric oxide in humans by pharmacological means can ameliorate sodium sensitivity has not been investigated. Because nebivolol has been demonstrated to increase nitric oxide bioactivity in both laboratory and clinical investigations, we hypothesized that nebivolol might ameliorate sodium sensitivity and improve renal sodium handling in comparison to metoprolol. We therefore conducted a randomized, 2-treatment-period crossover trial in 19 Hispanic postmenopausal women with hypertension to determine the comparative effects of nebivolol versus metoprolol on (1) 24-hour ambulatory blood pressure response to an increase in dietary sodium from 5 days of low sodium to 5 days of high sodium, (2) renal natriuretic response to a 1-L saline challenge, and (3) asymmetrical dimethylarginine. Clinic blood pressure and heart rate were significantly reduced after 4 weeks of treatment with both nebivolol and metoprolol. Twenty-four-hour mean systolic blood pressure increased sharply from low sodium to high sodium for both nebivolol and metoprolol. Nevertheless, the increases in blood pressure did not differ between the 2 drugs: 7.7 (3.1, 12.3) mm Hg with metoprolol and 9.3 (4.6, 13.9) mm Hg with nebivolol (P=0.63). Furthermore, we observed no differences between the drugs in natriuretic response to saline challenge or asymmetrical dimethylarginine. In a sodium-sensitive population, at doses sufficient to produce reductions in blood pressure and heart rate, nebivolol did not demonstrate a significant effect on sodium sensitivity or sodium handling compared with metoprolol.",
keywords = "hypertension, kidney, nitric oxide, sodium",
author = "Preston, {Richard A} and David Afshartous and Materson, {Barry J} and Rolando Rodco and Alonso, {Alberto B.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.114.03476",
language = "English",
volume = "64",
pages = "287--295",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive hispanic postmenopausal women

AU - Preston, Richard A

AU - Afshartous, David

AU - Materson, Barry J

AU - Rodco, Rolando

AU - Alonso, Alberto B.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Several consistent lines of evidence indicate an association between sodium sensitivity and impaired nitric oxide bioactivity. Nevertheless, whether restoring nitric oxide in humans by pharmacological means can ameliorate sodium sensitivity has not been investigated. Because nebivolol has been demonstrated to increase nitric oxide bioactivity in both laboratory and clinical investigations, we hypothesized that nebivolol might ameliorate sodium sensitivity and improve renal sodium handling in comparison to metoprolol. We therefore conducted a randomized, 2-treatment-period crossover trial in 19 Hispanic postmenopausal women with hypertension to determine the comparative effects of nebivolol versus metoprolol on (1) 24-hour ambulatory blood pressure response to an increase in dietary sodium from 5 days of low sodium to 5 days of high sodium, (2) renal natriuretic response to a 1-L saline challenge, and (3) asymmetrical dimethylarginine. Clinic blood pressure and heart rate were significantly reduced after 4 weeks of treatment with both nebivolol and metoprolol. Twenty-four-hour mean systolic blood pressure increased sharply from low sodium to high sodium for both nebivolol and metoprolol. Nevertheless, the increases in blood pressure did not differ between the 2 drugs: 7.7 (3.1, 12.3) mm Hg with metoprolol and 9.3 (4.6, 13.9) mm Hg with nebivolol (P=0.63). Furthermore, we observed no differences between the drugs in natriuretic response to saline challenge or asymmetrical dimethylarginine. In a sodium-sensitive population, at doses sufficient to produce reductions in blood pressure and heart rate, nebivolol did not demonstrate a significant effect on sodium sensitivity or sodium handling compared with metoprolol.

AB - Several consistent lines of evidence indicate an association between sodium sensitivity and impaired nitric oxide bioactivity. Nevertheless, whether restoring nitric oxide in humans by pharmacological means can ameliorate sodium sensitivity has not been investigated. Because nebivolol has been demonstrated to increase nitric oxide bioactivity in both laboratory and clinical investigations, we hypothesized that nebivolol might ameliorate sodium sensitivity and improve renal sodium handling in comparison to metoprolol. We therefore conducted a randomized, 2-treatment-period crossover trial in 19 Hispanic postmenopausal women with hypertension to determine the comparative effects of nebivolol versus metoprolol on (1) 24-hour ambulatory blood pressure response to an increase in dietary sodium from 5 days of low sodium to 5 days of high sodium, (2) renal natriuretic response to a 1-L saline challenge, and (3) asymmetrical dimethylarginine. Clinic blood pressure and heart rate were significantly reduced after 4 weeks of treatment with both nebivolol and metoprolol. Twenty-four-hour mean systolic blood pressure increased sharply from low sodium to high sodium for both nebivolol and metoprolol. Nevertheless, the increases in blood pressure did not differ between the 2 drugs: 7.7 (3.1, 12.3) mm Hg with metoprolol and 9.3 (4.6, 13.9) mm Hg with nebivolol (P=0.63). Furthermore, we observed no differences between the drugs in natriuretic response to saline challenge or asymmetrical dimethylarginine. In a sodium-sensitive population, at doses sufficient to produce reductions in blood pressure and heart rate, nebivolol did not demonstrate a significant effect on sodium sensitivity or sodium handling compared with metoprolol.

KW - hypertension

KW - kidney

KW - nitric oxide

KW - sodium

UR - http://www.scopus.com/inward/record.url?scp=84904460971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904460971&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.114.03476

DO - 10.1161/HYPERTENSIONAHA.114.03476

M3 - Article

C2 - 24842917

AN - SCOPUS:84904460971

VL - 64

SP - 287

EP - 295

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -